The calprotectin and lactoferrin rapid test (OIBD-625) is a CE-marked IVD combination test for the qualitative detection of calprotectin and lactoferrin in a human stool sample. The test is intended for use by healthcare professionals only. The result is read at the 5-minute mark.
The test can be used to support the assessment of inflammatory gastrointestinal diseases. It does not measure the exact concentration of markers and does not on its own confirm the diagnosis of Crohn’s disease, ulcerative colitis, or any other disease. The results are evaluated in conjunction with other clinical data available to the physician.
What do calprotectin and lactoferrin tell us?
Calprotectin is a calcium-binding protein complex found in neutrophils. In the case of intestinal inflammation, neutrophils are transferred to the intestinal mucosa and calprotectin can end up in the stool. It acts as a marker of intestinal inflammation.
Lactoferrin is a glycoprotein derived from neutrophils. Faecal lactoferrin can be used to support the assessment of intestinal inflammation. The discovery of a marker alone does not indicate the cause of inflammation.
How is the test done?
Always follow the instructions for use on the package. The test, sample and buffer should be allowed to warm up to 15–30 °C. At least three points of solid faeces should be sampled with a swab; the sample should not be scraped into a tube. Liquid samples should be handled according to separate instructions in the instructions for use.
The sample is mixed into the extraction buffer and the tube is allowed to stand for 2 minutes. Add 2 full drops of the extracted sample to each sample well of the test cassette and start the timer. Read the results at the 5-minute mark.
How is the result interpreted?
Each marker is interpreted separately. The C and T lines mean a positive result; a faint T line is also positive. A simple C line indicates a negative result. If the C line is missing, the result is null and void and the test is repeated with a new test cassette.
How reliable is the test?
In the manufacturer’s comparison with another commercial rapid test, the relative sensitivity of the calprotectin assay was 97.8%, the relative specificity was 99.0%, and the overall accuracy was 98.5% (336 samples). The corresponding values for the lactoferrin assay were 97.6%, 98.3% and 98.1% (162 samples). These are test-specific comparison results, not certainties of the diagnosis of an individual disease.
What’s in the box?
The test cassettes are individually packaged in foil bags. Included are the sampling tubes with extraction buffers and the user manual. The sampling container, timer and the necessary pipettes are purchased separately according to the instructions for use.
Frequently Asked Questions
Does the test give an accurate calprotectin value?
No. The test is qualitative: it indicates the presence of a tracer based on the detection limit of the test, but does not provide a numerical concentration.
Can a test alone confirm an IBD diagnosis?
No. The result is part of the overall clinical assessment. An inconclusive result requires other clinical trials.
Is the test a home test?
No. According to the manufacturer’s user manual, the OIBD-625 is a professional IVD test only.
Manufacturer’s product material in English (PDF). Always follow the up-to-date instructions for use in the package supplied.







